[ALA] YoY Quarter Result on 30-Sep-2016 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2016
Financial Year
2017
Quarter
30-Sep-2016 [#Q1]
Profit Trend
QoQ- -97.90%
YoY- 48.01%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 192 427 202 195 1,419 1,523 3,121 -37.15%
PBT -3,850 -435 -1,113 -527 -906 -979 -166 68.83%
Tax 0 0 0 56 0 -6 0 -
NP -3,850 -435 -1,113 -471 -906 -972 -166 68.83%
Tax Rate - - - - - - - -
Total Cost 4,041 862 1,315 666 2,325 2,495 3,287 3.50%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -2,008.97 -101.83 -551.87 -240.94 -63.82 -63.87 -5.32 168.72%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.03 -0.00 -0.02 -0.01 -0.02 -0.03 -0.01 20.08%
EPS Diluted -0.03 -0.00 -0.02 -0.01 -0.02 -0.02 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.